Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany A Traina

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Surgical Oncology Clinics of North America|September 10, 2013
Advances in molecular and clinical subtyping of breast cancer and their implications for therapyKaren A Cadoo, Tiffany A Traina, Tari A King
Women'S Health (London, England)|December 17, 2009
Bevacizumab for advanced breast cancerShari B Goldfarb, Tiffany A Traina, Maura N Dickler
Gynecologic Oncology|September 24, 2004
Weekly topotecan for recurrent endometrial cancer: a case series and review of the literatureTiffany A Traina, Paul Sabbatini, Carol Aghajanian, et al.
Targeted Oncology|October 31, 2009
Targeting insulin-like growth factor type 1 receptor in cancer therapyFrancesco Atzori, Tiffany A Traina, Maria Teresa Ionta, et al.
AIDS Patient Care and Stds|May 21, 2014
Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?Lalitha Parameswaran, Ying Taur, Monika K Shah, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
Endocrine-Related Cancer|February 28, 2015
Targeting the androgen receptor in prostate and breast cancer: several new agents in developmentTracy Proverbs-Singh, Jarett L Feldman, Michael J Morris, et al.
JCO Oncology Practice|January 7, 2026
Real-World Treatment Patterns and Outcomes for Patients With Metastatic Triple-Negative Breast Cancer in the United States: An Observational StudySimon M Collin, Sam Hillman, Chintal H Shah, et al.
Breast Disease|June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modelingTiffany A Traina, Ute Dugan, Brian Higgins, et al.
NPJ Breast Cancer|January 19, 2024
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancerKelly E McCann, Shari B Goldfarb, Tiffany A Traina, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Surgical Oncology Clinics of North America|September 10, 2013
Advances in molecular and clinical subtyping of breast cancer and their implications for therapyKaren A Cadoo, Tiffany A Traina, Tari A King
Women'S Health (London, England)|December 17, 2009
Bevacizumab for advanced breast cancerShari B Goldfarb, Tiffany A Traina, Maura N Dickler
Gynecologic Oncology|September 24, 2004
Weekly topotecan for recurrent endometrial cancer: a case series and review of the literatureTiffany A Traina, Paul Sabbatini, Carol Aghajanian, et al.
Targeted Oncology|October 31, 2009
Targeting insulin-like growth factor type 1 receptor in cancer therapyFrancesco Atzori, Tiffany A Traina, Maria Teresa Ionta, et al.
AIDS Patient Care and Stds|May 21, 2014
Tolerability of chemotherapy in HIV-infected women with breast cancer: are there prognostic implications?Lalitha Parameswaran, Ying Taur, Monika K Shah, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
Endocrine-Related Cancer|February 28, 2015
Targeting the androgen receptor in prostate and breast cancer: several new agents in developmentTracy Proverbs-Singh, Jarett L Feldman, Michael J Morris, et al.
JCO Oncology Practice|January 7, 2026
Real-World Treatment Patterns and Outcomes for Patients With Metastatic Triple-Negative Breast Cancer in the United States: An Observational StudySimon M Collin, Sam Hillman, Chintal H Shah, et al.
Breast Disease|June 4, 2010
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modelingTiffany A Traina, Ute Dugan, Brian Higgins, et al.
NPJ Breast Cancer|January 19, 2024
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancerKelly E McCann, Shari B Goldfarb, Tiffany A Traina, et al.
Pageof 7